Related Posts
ISN Journal summaries on conventional cytotoxic chemotherapy and Taiwan’s living kidney donation policy
Kidney International® Conventional cytotoxic chemotherapy–associated nephrotoxicity: consensus report of the 34th Acute... read more
Reflecting on progress and looking ahead: 10 years of the ISN-Global Kidney Health Atlas
As you continue to use ISN-Global Kidney Health Atlas (ISN-GKHA) data in your... read more
Redesigning kidney trials for improved evidence and patient care
“If a drug improves creatinine but makes a patient too fatigued... read more
10 years of Kidney International Reports®: transforming how kidney science is shared
“We are truly a global journal: We do not just select [from]... read more
Why do we still know so little about CKDu? Listen to the latest Global Kidney Care Podcast
Why does chronic kidney disease of unknown origin (CKDu) remain so... read more
ISN Journal summaries on B cell-targeting immunotherapies and eGFR slope in the cardiorenal continuum
Kidney International® Tiny warriors, big impact: targeted immunotherapy in kidney diseases This review... read more
From intravenous aminophylline to genomic testing: What did we learn from WCN’26 abstract award winners?
The WCN’26 interviews with abstract award winners offer a snapshot of... read more
Recent key kidney health studies in one place: Explore a special edition of ISN TrialWatch
Can lower-exposure tacrolimus plus everolimus improve outcomes in older kidney transplant... read more
Plan stronger CKDu research with the new ISN i3C Toolkit
What if better research approaches could help take the “unknown” out of chronic kidney disease... read more
Explore WCN’26 late-breaking trials with NephJC and Kidney International Reports®
NephJC has extended the conversation around WCN’26 late-breaking trials with expert commentary... read more
